| Analysis | Metabolite Name | Measured Value | Units | Strain | Treatment |
|---|---|---|---|---|---|
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 129000 | Peak area | CRBN +/+ | anti-CD3 stimulation |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 145000 | Peak area | CRBN +/+ | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 154000 | Peak area | CRBN +/+ | unstimulated |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 191000 | Peak area | CRBN +/+ | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 193000 | Peak area | CRBN -/- | anti-CD3 stimulation |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 200000 | Peak area | CRBN -/- | unstimulated |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 203000 | Peak area | CRBN +/+ | anti-CD3 stimulation |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 213000 | Peak area | CRBN +/+ | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 232000 | Peak area | CRBN +/+ | unstimulated |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 240000 | Peak area | CRBN +/+ | anti-CD3 stimulation |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 265000 | Peak area | CRBN -/- | unstimulated |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 282000 | Peak area | CRBN +/+ | anti-CD3 stimulation |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 303000 | Peak area | CRBN +/+ | unstimulated |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 334000 | Peak area | CRBN -/- | anti-CD3 stimulation |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 337000 | Peak area | CRBN -/- | unstimulated |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 372000 | Peak area | CRBN -/- | anti-CD3 stimulation |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 374000 | Peak area | CRBN +/+ | unstimulated |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 375000 | Peak area | CRBN +/+ | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 406000 | Peak area | CRBN +/+ | unstimulated |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 459000 | Peak area | CRBN +/+ | unstimulated |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 583000 | Peak area | CRBN +/+ | anti-CD3 stimulation |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 588000 | Peak area | CRBN +/+ | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 624000 | Peak area | CRBN -/- | anti-CD3 stimulation |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 661000 | Peak area | CRBN -/- | anti-CD3 stimulation |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 756000 | Peak area | CRBN -/- | unstimulated |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 765000 | Peak area | CRBN -/- | anti-CD3 stimulation |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 822000 | Peak area | CRBN -/- | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 826000 | Peak area | CRBN -/- | unstimulated |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 837000 | Peak area | CRBN +/+ | anti-CD3 stimulation |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 865000 | Peak area | CRBN -/- | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 1150000 | Peak area | CRBN -/- | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 1170000 | Peak area | CRBN -/- | unstimulated |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 1270000 | Peak area | CRBN +/+ | anti-CD3 stimulation |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 1640000 | Peak area | CRBN -/- | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 2250000 | Peak area | CRBN -/- | anti-CD3 stimulation |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 3310000 | Peak area | CRBN +/+ | unstimulated |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 3600000 | Peak area | CRBN -/- | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 6770000 | Peak area | CRBN +/+ | anti-CD3 stimulation |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 7270000 | Peak area | CRBN +/+ | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 7940000 | Peak area | CRBN -/- | unstimulated |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 8810000 | Peak area | CRBN +/+ | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 9070000 | Peak area | CRBN -/- | anti-CD3 stimulation |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 10800000 | Peak area | CRBN +/+ | unstimulated |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 14000000 | Peak area | CRBN -/- | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 14900000 | Peak area | CRBN -/- | unstimulated |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 16000000 | Peak area | CRBN +/+ | anti-CD3 stimulation |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 22600000 | Peak area | CRBN +/+ | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 23800000 | Peak area | CRBN +/+ | unstimulated |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 26700000 | Peak area | CRBN +/+ | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 47000000 | Peak area | CRBN -/- | unstimulated |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 48000000 | Peak area | CRBN +/+ | anti-CD3 stimulation |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 53300000 | Peak area | CRBN +/+ | unstimulated |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 71100000 | Peak area | CRBN -/- | anti-CD3 stimulation |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 149000000 | Peak area | CRBN -/- | anti-CD3 stimulation |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 201000000 | Peak area | CRBN -/- | unstimulated |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 245000000 | Peak area | CRBN +/+ | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 683000000 | Peak area | CRBN -/- | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 890000000 | Peak area | CRBN -/- | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 1140000000 | Peak area | CRBN -/- | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | 3-(2-HYDROXYPHENYL)PROPANOATE | 1810000000 | Peak area | CRBN -/- | anti-CD3 & anti-CD28 stimulation |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|